Cargando…

Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada

BACKGROUND: Regional variation in medical care costs can indicate heterogeneity in clinical practice, inequities in access, or inefficiencies in service delivery. We aimed to estimate regional variation in medical costs for people living with HIV (PLHIV), adjusting for demographics and case-mix. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Enns, Benjamin, Min, Jeong Eun, Panagiotoglou, Dimitra, Montaner, Julio S. G., Nosyk, Bohdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724338/
https://www.ncbi.nlm.nih.gov/pubmed/31481056
http://dx.doi.org/10.1186/s12913-019-4391-8
_version_ 1783448971148001280
author Enns, Benjamin
Min, Jeong Eun
Panagiotoglou, Dimitra
Montaner, Julio S. G.
Nosyk, Bohdan
author_facet Enns, Benjamin
Min, Jeong Eun
Panagiotoglou, Dimitra
Montaner, Julio S. G.
Nosyk, Bohdan
author_sort Enns, Benjamin
collection PubMed
description BACKGROUND: Regional variation in medical care costs can indicate heterogeneity in clinical practice, inequities in access, or inefficiencies in service delivery. We aimed to estimate regional variation in medical costs for people living with HIV (PLHIV), adjusting for demographics and case-mix. METHODS: We conducted a retrospective cohort study using linked health administrative databases of PLHIV, from 2010 to 2014, in British Columbia (BC), Canada. Quarterly health care costs (2018 CAD) were derived from inpatient, outpatient, prescription drugs, antiretroviral therapy (ART), and HIV diagnostics. We used a two-part model with a logit link for the probability of incurring costs, and a log link and gamma distribution for observations with positive costs. We also estimated quarterly utilization rates for hospitalization-, physician billing- and prescription drug-days. Primary variables were indicators of individuals’ Health Service Delivery Area (HSDA). We adjusted cost and utilization estimates for demographic characteristics, HIV-disease progression, and comorbidities. RESULTS: Our cohort included 9577 PLHIV (median age 45.5 years, 80% male). Adjusted total quarterly costs for all 16 HSDAs were within 20% of the provincial mean, 8/16 for hospitalization costs, 16/16 for physician billing costs and 10/16 for prescription drug costs. Northern Interior and Northeast HSDAs had 38 and 44% lower quarterly non-ART prescription drug costs, and 2 and 5% higher quarterly inpatient costs, respectively. CONCLUSIONS: We observed limited variation in medical care costs and utilization among PLHIV in BC. However, lower levels of outpatient care and higher levels of inpatient care indicate possible barriers to accessing care among PLHIV in the most rural regions of the province. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-019-4391-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6724338
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67243382019-09-10 Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada Enns, Benjamin Min, Jeong Eun Panagiotoglou, Dimitra Montaner, Julio S. G. Nosyk, Bohdan BMC Health Serv Res Research Article BACKGROUND: Regional variation in medical care costs can indicate heterogeneity in clinical practice, inequities in access, or inefficiencies in service delivery. We aimed to estimate regional variation in medical costs for people living with HIV (PLHIV), adjusting for demographics and case-mix. METHODS: We conducted a retrospective cohort study using linked health administrative databases of PLHIV, from 2010 to 2014, in British Columbia (BC), Canada. Quarterly health care costs (2018 CAD) were derived from inpatient, outpatient, prescription drugs, antiretroviral therapy (ART), and HIV diagnostics. We used a two-part model with a logit link for the probability of incurring costs, and a log link and gamma distribution for observations with positive costs. We also estimated quarterly utilization rates for hospitalization-, physician billing- and prescription drug-days. Primary variables were indicators of individuals’ Health Service Delivery Area (HSDA). We adjusted cost and utilization estimates for demographic characteristics, HIV-disease progression, and comorbidities. RESULTS: Our cohort included 9577 PLHIV (median age 45.5 years, 80% male). Adjusted total quarterly costs for all 16 HSDAs were within 20% of the provincial mean, 8/16 for hospitalization costs, 16/16 for physician billing costs and 10/16 for prescription drug costs. Northern Interior and Northeast HSDAs had 38 and 44% lower quarterly non-ART prescription drug costs, and 2 and 5% higher quarterly inpatient costs, respectively. CONCLUSIONS: We observed limited variation in medical care costs and utilization among PLHIV in BC. However, lower levels of outpatient care and higher levels of inpatient care indicate possible barriers to accessing care among PLHIV in the most rural regions of the province. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-019-4391-8) contains supplementary material, which is available to authorized users. BioMed Central 2019-09-03 /pmc/articles/PMC6724338/ /pubmed/31481056 http://dx.doi.org/10.1186/s12913-019-4391-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Enns, Benjamin
Min, Jeong Eun
Panagiotoglou, Dimitra
Montaner, Julio S. G.
Nosyk, Bohdan
Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada
title Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada
title_full Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada
title_fullStr Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada
title_full_unstemmed Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada
title_short Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada
title_sort geographic variation in the costs of medical care for people living with hiv in british columbia, canada
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724338/
https://www.ncbi.nlm.nih.gov/pubmed/31481056
http://dx.doi.org/10.1186/s12913-019-4391-8
work_keys_str_mv AT ennsbenjamin geographicvariationinthecostsofmedicalcareforpeoplelivingwithhivinbritishcolumbiacanada
AT minjeongeun geographicvariationinthecostsofmedicalcareforpeoplelivingwithhivinbritishcolumbiacanada
AT panagiotogloudimitra geographicvariationinthecostsofmedicalcareforpeoplelivingwithhivinbritishcolumbiacanada
AT montanerjuliosg geographicvariationinthecostsofmedicalcareforpeoplelivingwithhivinbritishcolumbiacanada
AT nosykbohdan geographicvariationinthecostsofmedicalcareforpeoplelivingwithhivinbritishcolumbiacanada
AT geographicvariationinthecostsofmedicalcareforpeoplelivingwithhivinbritishcolumbiacanada